The allosteric IDH1 inhibitor ivosidenib overcomes chemoresistance in intrahepatic cholangiocarcinoma models expressing wild-type IDH1

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci199730
Affiliations:
5
Authors:
10
Go to article
Institutions Authors Share
Sun Yat-sen Memorial Hospital, SYSU, China
7.500000
 0.75
Guangdong-Hong Kong Joint Laboratory for RNA Medicine, China
2.000000
 0.20
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China
0.500000
 0.05
Interested in Oncology and Carcinogenesis?